Evenamide

DRUG2 trials

Sponsors

Newron Pharmaceuticals SPA

Conditions

HealthySchizophrenia

Phase 1

An Open Label, Single-Dose Study of 14C-NW-3509 in Healthy Male Subjects

Newron Pharmaceuticals SPAHealthy

Start: 2018-04-02End: 2018-06-30Target: 6Updated: 2018-06-19

Phase 2

Study to Determine the Safety, Tolerability, and Efficacy of Evenamide in Patients With Chronic Schizophrenia

CompletedNCT04461119

Newron Pharmaceuticals SPASchizophrenia

Start: 2020-06-16End: 2021-03-13Updated: 2021-05-20